Skip to main content
Conan G. Kinsey
( out of 39 reviews )

Conan G. Kinsey, MD, PhD

Languages spoken: English

Clinical Locations

Huntsman Cancer Institute - Cancer Hospital South

Clinic 3A, Gastrointestinal
801-587-4700
  • Board Certification

    American Board of Internal Medicine

    Patient Rating

    5.0 /5
    ( out of 39 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    August 14, 2023
    HUNTSMAN CANCER CENTER

    happy with everyone thank one

    August 04, 2023
    HUNTSMAN CANCER CENTER

    Dr Kinsey is fantastic. He explains things in a way that I can understand. He always takes time to answer all questions.

    July 21, 2023
    HUNTSMAN CANCER CENTER

    He is very pleasant, he explained all my tests results and what the next steps were. I had concerns and Dr.Kinsey explained everything.

    May 05, 2023
    HUNTSMAN CANCER CENTER

    Dr Kinsey explained things to me in a way that reassured me about the concerns I have. He answered every one of my questions in a way that I understand.

    May 05, 2023
    HUNTSMAN CANCER CENTER

    Highly recommended!

    May 01, 2023
    HUNTSMAN CANCER CENTER

    Dr. Kinsey's hopeful energy is wonderful and uplifting.

    April 15, 2023
    HUNTSMAN CANCER CENTER

    he is very personable and helps me understand what is going on with my treatments

    March 02, 2023
    HUNTSMAN CANCER CENTER

    Dr. Kinsey is an excellent communicator as well as a highly skilled physician.

    February 24, 2023
    HUNTSMAN CANCER CENTER

    have trust in Dr Kinsey and his staff

  • Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Oncological Sciences -Adjunct
    Academic Divisions Occupational Therapy
    Board Certification
    American Board of Internal Medicine

    Education history

    Postdoctoral Fellowship Hematology/Oncology - Huntsman Cancer Institute Postdoctoral Fellow
    Hematology/Oncology - Huntsman Cancer Institute Fellow
    Residency Internal Medicine - University of Utah School of Medicine Resident
    Genetics and Medicine - University of Rochester School of Medicine and Dentistry M.D., Ph.D.
    Undergraduate Cell Biology/Biochemistry - Bucknell University B.S.

    Selected Publications

    Journal Article

    1. Vaishnavi A, Kinsey CG, McMahon M (2023). Preclinical Modeling of Pathway-Targeted Therapy of Human Lung Cancer in the Mouse. Cold Spring Harb Perspect Med. (Read full article)
    2. Vaishnavi A, Juan J, Jacob M, Stehn C, Gardner EE, Scherzer MT, Schuman S, Van Veen JE, Murphy B, Hackett CS, Dupuy AJ, Chmura SA, van der Weyden L, Newberg JY, Liu A, Mann K, Rust AG, Weiss WA, Kinsey CG, Adams DJ, Grossmann A, Mann MB, McMahon M (2021). Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis. Cancer Res, 82(22), 4261-4273. (Read full article)
    3. Foth M, Garrido-Laguna I, Kinsey CG (2021). Therapeutic Targeting of Autophagy in Pancreatic Cancer. Surg Oncol Clin N Am, 30(4), 709-718. (Read full article)
    4. Truong A, Yoo JH, Scherzer MT, Sanchez JMS, Dale KJ, Kinsey CG, Richards JR, Shin D, Ghazi PC, Onken MD, Blumer KJ, Odelberg SJ, McMahon M (2020). Chloroquine Sensitizes GNAQ/11-mutated Melanoma to MEK1/2 Inhibition. Clin Cancer Res, 26(23), 6374-6386. (Read full article)
    5. Vaishnavi A, Scherzer MT, Kinsey CG, Parkman GL, Truong A, Ghazi P, Schuman S, Battistone B, Garrido-Laguna I, McMahon M (2019). Inhibition of MEK1/2 Forestalls the Onset of Acquired Resistance to Entrectinib in Multiple Models of NTRK1-Driven Cancer. Cell Rep, 32(5), 107994. (Read full article)
    6. Kinsey C, Balakrishnan V, ODell MR, Huang JL, Newman L, Whitney-Miller CL, Hezel AF, Land H (2014). Plac8 links oncogenic mutations to regulation of autophagy and is critical to pancreatic cancer progression. Cell Rep, 7(4), 1143-55. (Read full article)
    7. McMurray HR, Sampson ER, Compitello G, Kinsey C, Newman L, Smith B, Chen SR, Klebanov L, Salzman P, Yakovlev A, Land H (2008). Synergistic response to oncogenic mutations defines gene class critical to cancer phenotype. Nature, 453(7198), 1112-6. (Read full article)
    8. Kinsey CG, Bussolati G, Bosco M, Kimura T, Pizzorno MC, Chernin MI, Cassoni P, Novak JF (2007). Constitutive and ligand-induced nuclear localization of oxytocin receptor. J Cell Mol Med, 11(1), 96-110. (Read full article)
    9. Takahashi M, Chernin MI, Yamamoto O, Tonzetich J, Kinsey CG, Novak JF (2002). Transformation of MC3T3-E1 cells following stress and transfection with pSV2neo plasmid. Anticancer Res, 22(2A), 585-98. (Read full article)

    Review

    1. Gajiwala S, Torgeson A, Garrido-Laguna I, Kinsey C, Lloyd S (2018). Combination immunotherapy and radiation therapy strategies for pancreatic cancer-targeting multiple steps in the cancer immunity cycle. [Review]. J Gastrointest Oncol, 9(6), 1014-1026. (Read full article)

    Book Chapter

    1. Gilcrease GW, Kinsey C, Stenehjem D (2015). Environmental and genetic risk factors in hepatocellular carcinoma. In Torre A, Uscanga L (Eds.), Medicina Individualizada De La Evidencia A La Práctica Clínica (pp. 155-62). Permanyer México.
  • News & Podcasts

    Huntsman Cancer Institute News